Position in BIO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$360,846
+$18,263 QoQ
Shares Held
1,229
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#227
of 397 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026DNB Asset Management AS holds $329,512,022 across 19 Medical Devices names. BIO ranks #18 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DXCM |
Dexcom Inc
|
1,255,284 | $84,543,377 | |
| 2 | ABT |
Abbott Laboratories
|
841,310 | $76,340,469 | |
| 3 | BSX |
Boston Scientific Corp
|
1,042,751 | $44,504,612 | |
| 4 | EW |
Edwards Lifesciences Corp
|
271,421 | $24,552,743 | |
| 5 | SYK |
Stryker Corp
|
75,658 | $23,820,164 | |
| 6 | MDT |
Medtronic plc
|
280,478 | $21,941,793 | |
| 7 | PODD |
Insulet Corp
|
104,825 | $15,959,606 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
100,876 | $6,457,072 |
All Filings in BIO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $360,846 | 1,229 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $342,583 | 1,229 | Shares | Other | 2026-05-14 | |
| 2025-03-31 | $891,673 | 3,661 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $1,130,074 | 3,440 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $1,057,607 | 3,161 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $933,763 | 3,419 | Shares | Other | 2024-07-05 | |
| 2024-03-31 | $1,093,295 | 3,161 | Shares | Other | 2024-04-12 | |
| No filing history on record for this holder in this stock. | ||||||